The purpose of this work was to investigate the presence of pathogenic bacteria in lesions of patients with cutaneous leishmaniasis wounds and the pattern of susceptibility to antibiotics, in order to study the prevalence of secondary bacterial infection in ulcerated lesions and its relationship to the healing process. Twenty samples from leishmaniotic patients attended at the Institute of Endemic Diseases-University of Khartoum were evaluated. The criteria for inclusion of patients in this work were based on a positive clinical diagnosis of CL ulcer together with laboratory analysis. The bacteria isolated were Staphylococcus aureus in 9 cases (45%), coagulase negative Staphylococcus in 11 cases (55%). Forty four percent of the S. aureus w...
Background: Bacterial infections are seen in patients with visceral leishmaniasis. This study was co...
Leishmaniasis is widely seen in tropical and subtropical regions of the world. It is caused by oblig...
Meglumine antimoniate is a first line drug for the treatment of visceral leish-maniasis. During the ...
Background: Cutaneous Leishmaniasis (CL) is a parasitic disease characterized by single or multiple...
Background and Objectives. Visceral leishmaniasis (VL) is one of the neglected diseases affecting th...
Wound infection is a global cause of morbidity and mortality across all wound types. Therefore, effi...
and Farnaz Hamidi. This is an open access article distributed under the Creative Commons Attribution...
International audienceEight patients with cutaneous ulcers were referred to the Institute of Endemic...
Identification and antimicrobial susceptibility of micro-organisms recovered from cutaneous lesions ...
BACKGROUND Cutaneous leishmaniasis (CL) generally presents with a single or several localised cutan...
SummaryBackgroundThe consequences of the spread of Leishmania parasites to the blood from lesions in...
We investigated the bacterial flora present in skin lesions of patients with chiclero's ulcer from t...
Cutaneous leishmaniasis due to L.major is now endemic in many parts of the northern Sudan. In this u...
Foi estudada a flora bacteriana em úlceras leishmanióticas, destacando-se o encontro das espécies ae...
We investigated the bacterial flora present in skin lesions of patients with chiclero's ulcer from t...
Background: Bacterial infections are seen in patients with visceral leishmaniasis. This study was co...
Leishmaniasis is widely seen in tropical and subtropical regions of the world. It is caused by oblig...
Meglumine antimoniate is a first line drug for the treatment of visceral leish-maniasis. During the ...
Background: Cutaneous Leishmaniasis (CL) is a parasitic disease characterized by single or multiple...
Background and Objectives. Visceral leishmaniasis (VL) is one of the neglected diseases affecting th...
Wound infection is a global cause of morbidity and mortality across all wound types. Therefore, effi...
and Farnaz Hamidi. This is an open access article distributed under the Creative Commons Attribution...
International audienceEight patients with cutaneous ulcers were referred to the Institute of Endemic...
Identification and antimicrobial susceptibility of micro-organisms recovered from cutaneous lesions ...
BACKGROUND Cutaneous leishmaniasis (CL) generally presents with a single or several localised cutan...
SummaryBackgroundThe consequences of the spread of Leishmania parasites to the blood from lesions in...
We investigated the bacterial flora present in skin lesions of patients with chiclero's ulcer from t...
Cutaneous leishmaniasis due to L.major is now endemic in many parts of the northern Sudan. In this u...
Foi estudada a flora bacteriana em úlceras leishmanióticas, destacando-se o encontro das espécies ae...
We investigated the bacterial flora present in skin lesions of patients with chiclero's ulcer from t...
Background: Bacterial infections are seen in patients with visceral leishmaniasis. This study was co...
Leishmaniasis is widely seen in tropical and subtropical regions of the world. It is caused by oblig...
Meglumine antimoniate is a first line drug for the treatment of visceral leish-maniasis. During the ...